Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Kevin Bray"'
Autor:
Berg Dodson, Ryan Goul, Angelo Marshall, Aafiya, Kevin Bray, Dan Ewing, Michael Walsh, Judy Z Wu
Publikováno v:
Nano Express, Vol 5, Iss 2, p 025001 (2024)
Ultrathin (sub-2 nm) Al _2 O _3 /MgO memristors were recently developed using an in vacuo atomic layer deposition (ALD) process that minimizes unintended defects and prevents undesirable leakage current. These memristors provide a unique platform tha
Externí odkaz:
https://doaj.org/article/79861b0abfa04be28e4492516704becf
Publikováno v:
Journal of the American College of Emergency Physicians Open, Vol 3, Iss 6, Pp n/a-n/a (2022)
Externí odkaz:
https://doaj.org/article/65b123d83e904f07920a1497b9f28e8b
Autor:
Lauric Haber, Kara Olson, Marcus P. Kelly, Alison Crawford, David J. DiLillo, Richard Tavaré, Erica Ullman, Shu Mao, Lauren Canova, Olga Sineshchekova, Jennifer Finney, Arpita Pawashe, Supriya Patel, Ryan McKay, Sahar Rizvi, Ermelinda Damko, Danica Chiu, Kristin Vazzana, Priyanka Ram, Katja Mohrs, Amanda D’Orvilliers, Jenny Xiao, Sosina Makonnen, Carlos Hickey, Cody Arnold, Jason Giurleo, Ya Ping Chen, Courtney Thwaites, Drew Dudgeon, Kevin Bray, Ashique Rafique, Tammy Huang, Frank Delfino, Aynur Hermann, Jessica R. Kirshner, Marc W. Retter, Robert Babb, Douglas MacDonald, Gang Chen, William C. Olson, Gavin Thurston, Samuel Davis, John C. Lin, Eric Smith
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
Abstract T-cell-redirecting bispecific antibodies have emerged as a new class of therapeutic agents designed to simultaneously bind to T cells via CD3 and to tumor cells via tumor-cell-specific antigens (TSA), inducing T-cell-mediated killing of tumo
Externí odkaz:
https://doaj.org/article/13db8e3e17e043ffbbadbbb6bb988d63
Autor:
Kevin P Nishimoto, Taylor Barca, Aruna Azameera, Amani Makkouk, Jason M Romero, Lu Bai, Mary M Brodey, Jackie Kennedy‐Wilde, Hui Shao, Stephanie Papaioannou, Amy Doan, Cynthia Masri, Ngoc T Hoang, Hayden Tessman, Vidhya Dhevi Ramanathan, Ana Giner‐Rubio, Frank Delfino, Kriti Sharma, Kevin Bray, Matthew Hoopes, Daulet Satpayev, Ranjita Sengupta, Marissa Herrman, Stewart E Abbot, Blake T Aftab, Zili An, Swapna Panuganti, Sandra M Hayes
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 2, Pp n/a-n/a (2022)
Abstract Objectives Autologous chimeric antigen receptor (CAR) αβ T‐cell therapies have demonstrated remarkable antitumor efficacy in patients with haematological malignancies; however, not all eligible cancer patients receive clinical benefit. E
Externí odkaz:
https://doaj.org/article/be2e5138abef45428e2a323fe55af735
Autor:
Kevin Bray, Robin Mathew, Alexandria Lau, Jurre J Kamphorst, Jing Fan, Jim Chen, Hsin-Yi Chen, Anahita Ghavami, Mark Stein, Robert S DiPaola, Donna Zhang, Joshua D Rabinowitz, Eileen White
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41831 (2012)
mTOR inhibitors are used clinically to treat renal cancer but are not curative. Here we show that autophagy is a resistance mechanism of human renal cell carcinoma (RCC) cell lines to mTOR inhibitors. RCC cell lines have high basal autophagy that is
Externí odkaz:
https://doaj.org/article/6ba4d2c1b1124f52914b4f6ce3ca12ad
Autor:
Eileen White, Robert S. DiPaola, Vassiliki Karantza-Wadsworth, Shridar Ganesan, Michael May, Cristina M. Karp, Hsin-Yi Chen, Kevin Bray
Supplementary Data from Bcl-2 Modulation to Activate Apoptosis in Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee1b95696173bcb6703299a413291b6
https://doi.org/10.1158/1541-7786.22518924.v1
https://doi.org/10.1158/1541-7786.22518924.v1
Autor:
Eileen White, Robert S. DiPaola, Vassiliki Karantza-Wadsworth, Shridar Ganesan, Michael May, Cristina M. Karp, Hsin-Yi Chen, Kevin Bray
Apoptosis resistance is a hallmark of cancer linked to disease progression and treatment resistance, which has led to the development of anticancer therapeutics that restore apoptotic function. Antiapoptotic Bcl-2 is frequently overexpressed in refra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708f06bbee332ef052a40e1fa7a3a7c0
https://doi.org/10.1158/1541-7786.c.6542181
https://doi.org/10.1158/1541-7786.c.6542181
Autor:
Kevin Bray, Kaitlin Burge, Om Patel, Ishant Yadav, William Haynes, Nicholas Van Wagoner, Charles A Khoury
Publikováno v:
Open Access Emergency Medicine.
Kevin Bray,1 Kaitlin Burge,1 Om Patel,1 Ishant Yadav,1 William Haynes,1 Nicholas Van Wagoner,2 Charles A Khoury3 1Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; 2Division of Infectious Diseases, University of A
Publikováno v:
Respiratory Medicine. 211:107195
Autor:
Corinne E. Decker, Jacqueline Idun, Katja Mohrs, Thomas Meagher, Kevin Bray, Iryna Petriv, Jonathon Golas, Timothy Helms, Dharani Ajithdoss, Gavin Thurston, John Lin, Jessica R. Kirshner, David J. DiLillo
Publikováno v:
Cancer Research. 83:1780-1780
The clinical success of cancer immunotherapy, including engineered T cell therapies, has revolutionized treatment paradigms and patient outcomes. While hematological tumors have benefited most from cell therapy approaches, the treatment of solid tumo